Aratana Therapeutics (PETX) IPO Prices at $6/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/29/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- BioNTech ends colorectal cancer mRNA therapy trial early
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Needham sees mature node semiconductor strength in latest tracker
Aratana Therapeutics (PETX) IPO Opens Higher
June 27, 2013 11:28 AM EDTThe IPO for Aratana Therapeutics (NASDAQ: PETX) opened for trading at $7 after pricing 5,750,000 share IPO at $6 per share, in-line with the expected pricing.
Stifel and Lazard Capital Markets are acting as lead book-running managers for the offering. William Blair, JMP Securities and Craig-Hallum... More
